Literature DB >> 11851840

Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors.

T Nakamura1, T Ozawa, T Kawasaki, H Nakamura, H Sugimura.   

Abstract

BACKGROUND AND AIMS: A few cases are reported of liver neoplasms observed in patients with glycogen storage disease type 1a (GSD1a). Genetic analysis was carried out in adult Japanese patients with GSD1a and their family members, and hepatic tumors were also investigated in these patients.
METHODS: DNA was extracted from the peripheral blood lymphocytes of 20 adult patients with GSD1a and 21 family members, and mutations were detected based on the differences in the polymerase chain reaction (PCR) products of the glucose-6-phosphatase (G6Pase) gene shown by single-strand conformation polymorphism (SSCP) analysis. Actual mutations were confirmed by direct sequencing. The relationship between the occurrence of liver tumors and the clinical characteristics of the patients was also investigated.
RESULTS: Nineteen of the 20 patients were homozygous for the G727T mutation and one was a compound heterozygote for G727T plus G327A mutations. All of the 19 homozygotes for G727T had hepatomegaly, three had hepatocellular carcinoma, one had cholangiocellular carcinoma, and seven had hepatic adenoma. There were no differences between the tumor and non-tumor groups with respect to laboratory biochemical data (P > 0.05). The mean age of G727T homozygotes with hepatocellular carcinoma was 48.3 years, and that of those with hepatic adenoma was approximately 20 years younger.
CONCLUSION: The G727T mutation seems to be common among Japanese patients with GSD1a, and the discovery of one heterozygote with a combination of G727T and G327A mutations (the latter mutation is common among Chinese) by the use of polymerase chain reaction-single strand conformation polymorphism analysis gave further insight into Japanese ancestry. This is the first study of liver tumors in a large group of adult GSD1a patients with the G727T mutation. As most of the patients in our series are free from other chronic liver diseases such as viral hepatitis, other genetic and/or acquired factors may have influence on the sequel to this metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11851840     DOI: 10.1046/j.1440-1746.2001.02645.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

Review 1.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

Review 2.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

3.  Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia.

Authors:  So Youn Kim; David A Weinstein; Matthew F Starost; Brian C Mansfield; Janice Y Chou
Journal:  J Hepatol       Date:  2007-12-28       Impact factor: 25.083

Review 4.  Glucose-6-phosphatase deficiency.

Authors:  Roseline Froissart; Monique Piraud; Alix Mollet Boudjemline; Christine Vianey-Saban; François Petit; Aurélie Hubert-Buron; Pascale Trioche Eberschweiler; Vincent Gajdos; Philippe Labrune
Journal:  Orphanet J Rare Dis       Date:  2011-05-20       Impact factor: 4.123

5.  Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.

Authors:  Fabian Peeks; Thomas A H Steunenberg; Foekje de Boer; M Estela Rubio-Gozalbo; Monique Williams; Rob Burghard; Fabienne Rajas; Maaike H Oosterveer; David A Weinstein; Terry G J Derks
Journal:  J Inherit Metab Dis       Date:  2017-04-10       Impact factor: 4.982

6.  Clinical features and diagnostic imaging of cholangiolocellular carcinoma compared with other primary liver cancers: a surgical perspective.

Authors:  Hiroyuki Takamura; Ryousuke Gabata; Yoshinao Obatake; Shinichi Nakanuma; Hironori Hayashi; Kazuto Kozaka; Motoko Sasaki; Mitsuyoshi Okazaki; Takahisa Yamaguchi; Hiroyuki Shimbashi; Shiro Terai; Koichi Okamoto; Isamu Makino; Jun Kinoshita; Keishi Nakamura; Tomoharu Miyashita; Hidehiro Tajima; Itasu Ninomiya; Sachio Fushida; Azusa Kitao; Masaaki Kitahara; Kuniaki Arai; Taro Yamashita; Tatsuya Yamashita; Hiroko Ikeda; Yasunori Satoh; Kenichi Harada; Syuichi Kaneko; Toshihumi Gabata; Tateo Kosaka; Tetsuo Ohta
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  Molecular, Biochemical, and Clinical Characterization of Thirteen Patients with Glycogen Storage Disease 1a in Malaysia.

Authors:  Siti Aishah Abdul Wahab; Yusnita Yakob; Mohd Khairul Nizam Mohd Khalid; Noraishah Ali; Huey Yin Leong; Lock Hock Ngu
Journal:  Genet Res (Camb)       Date:  2022-09-13       Impact factor: 1.375

8.  Development of Hepatocellular Carcinoma in Patients with Glycogen Storage Disease: a Single Center Retrospective Study.

Authors:  Hyo Jeong Jang; Hye Ran Yang; Jae Sung Ko; Jin Soo Moon; Ju Young Chang; Jeong Kee Seo
Journal:  J Korean Med Sci       Date:  2020-01-06       Impact factor: 2.153

9.  Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.

Authors:  Yoo-Mi Kim; Jin-Ho Choi; Beom-Hee Lee; Gu-Hwan Kim; Kyung-Mo Kim; Han-Wook Yoo
Journal:  Orphanet J Rare Dis       Date:  2020-02-11       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.